Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC

Investegate announcements from AstraZeneca PLC, AZN: Full year and Q4 2021 results

Related Keywords

China , Japan , Cambridge , Cambridgeshire , United Kingdom , United States , India , Akanuma , Tochigi , America , Covis Pharma Gmb , Losec Prilosec , Pascal Soriot , Amgen , Ionis Pharmaceuticals Inc , Nasdaq , Coalition For Epidemic Preparedness Innovations , Group Condensed Consolidated Financial , Group Financial , Company On Twitter Astrazeneca , Astrazeneca , European Union , China National Reimbursement Drug List , Group Core , International Accounting Standards Board , Alexion Acquisition Group , International Accounting Standards , Amgen Inc , World Health Organisation , Vaccine Alliance Gavi , Serum Institute Of India Pvt , Investor Relations Team , United International Accounting Standards , International Financial Reporting Standards Ifrss , Total Revenue , Chief Executive Officer , Emerging Markets , Group Review , Factual Change , Product Sales , Rare Disease , China Emerging Markets , Gross Profit Margin , Operating Expenses , Markets Total Revenue , Core Tax Rate , Gross Margin , Regional Total Revenue , Excluding Vaxzevria , North America , Ionis Pharmaceuticals , Covis Pharma Gmbh , Serum Institute , International Financial Reporting Standards , Vaxzevria Product Sale , Vaxzevria Total Revenue , Collaboration Revenue , National Reimbursement Drug , Core Gross Profit Margin , Global Access , Epidemic Preparedness Innovations , Vaccine Alliance , Drug Designation , Track Designation , Immune Therapies , New Medicines , Net Debt , Initial Collaboration Revenue , Ongoing Collaboration Revenue , Condensed Consolidated Financial , Annual Report , Income Statement , Reported Financial Measures , Intangible Asset Amortisation , Reported Profit Before Tax , Net Finance Expense , Joint Ventures , Condensed Financial Statements , Condensed Financial , Investegate Announcements , Investegate Company Announcements , Astrazeneca Plc , Egulatory News Service , Egulatory News Service And Regulatory , Ns ,